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Mixed epithelial and stromal tumor of the kidney (MESTK) is the term given to a class of uncommon biphasic tumors
of the kidney, with few reported cases. We describe eight cases of MESTK with detailed clinicopathological data and
follow-up information. With this report, we hope to increase clinical awareness that MESTK should be considered as
one of the possible diagnoses for cystic renal mass, especially in peri-menopausal women or those who receive
hormone therapy. In addition, regular follow-up is necessary for the any cases with malignant potential.
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Mixed epithelial and stromal tumor of the kidney
(MESTK), is a rare kidney tumor [1]. The tumor was
first identified by Michal and Syrucek in 1998 [2] and
has been ariously termed ‘cystic hamartoma of the renal
pelvis,’ ‘adult mesoblastic nephroma,’ ‘cystic nephroma,’ ‘ma-
ture nephroblastic tumor’ or ‘cystic partially differentiated
nephroblastoma.’ To date, approximately 100 cases have
been reported [3], with most of these reports focusing on
the pathological and radiological features of the tumors. In
this paper, we report detailed clinicopathological findings
and clinical outcomes of a series of MESTK cases, and
review the related literature.
Case presentation
During the period 2005 to 2012, eight cases with a diag-
nosis of MESTK were identified from the surgical path-
ology files of the urology department at our hospital.
The clinical information and pathological data were
obtained from the medical records, and demographic in-
formation, presenting symptoms, treatment, tumor size,
immunohistochemical staining profiles, and scheduled
follow-up data were collected.
The clinical features and follow-up data are summarized
in Table 1. Of the eight patients, six were women and two
were men. Mean age at presentation was 38 years. The* Correspondence: wangchaojundf@hotmail.com
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reproduction in any medium, provided the orinitial clinical presentation in one patient was flank pain,
but all the other cases were discovered incidentally during
regular examination. None of these patients had any
history of hormonal therapy. In all cases, the computed
tomography (CT) scan showed a partially cystic mass in the
kidney, which was classified as a Bosniak III or IV lesion,
indicating a pre-operative clinical impression of cystic renal
cancer (Figure 1). Thus all eight patients underwent either
nephrectomy or partial nephrectomy, and the diagnosis of
MESTK was made postoperatively.
On gross examination, the excised specimens were
found to be of varying size and consisted of multi-cystic
and solid septa. Histological examination showed that
all specimens were composed of cysts or dilated tubules of
diverse diameter. All specimens presented with the
characteristic mixture of epithelial and stromal components
(Figure 2A). The tubular glandular epithelium was scattered
within abundant spindle cells. Assays showed that the spec-
imens had diverse immunochemical profiles (Table 1).
The patients were followed up for a mean duration of
28 months (4 to 50 months); at the end of which, all eight
patients were alive without any evidence of recurrence
or metastasis.Discussion
MESTK, which was included in the WHO 2004 renal
tumor classification, is a rare and distinctive kidney tumor
composed of both epithelium and stroma with solid and
cystic architecture [4]. As reported previously [5,6], MESTK
occurs predominantly in middle-aged peri-menopausaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.









IHC profile Length of
follow-up, months
1 56 F Incidental Nephrectomy 4.5 Postive for ER and PR; negative for CD10 4
2 60 M Incidental Nephrectomy 3.5 Positive for CK, PR, SMA, desmin, and vimentin 6
3 40 F Incidental Nephrectomy 4 Positive for ER, PR, CK, vimentin, and CD10 19
4 58 M Incidental Nephrectomy 4 Positive for CK, CD10, ER, PR, vimentin, and
desmin; negative for Melan-A and HMB-45
23
5 54 F Incidental Partial Nephrectomy 3.5 Positive for ER and PR; negative for CD10 32
6 47 F Incidental Partial Nephrectomy 3.5 Positive for SMA, desmin, CD10, PR;
negative for HMB-45
42
7 33 F Pain Nephrectomy 9.5 Positive for desmin, CD99, and S-100; negative
for HMB-45, SMA, Myo-D1, CD31, and CD3
48
8 51 F Incidental Nephrectomy 7 Positive for ER, PR, desmin, and CD10; negative
for HMB-45
50
Abbreviations: CK, cytokeratin; ER, estrogen receptor; IHC, Immunohistochemistry; PR, progesterone receptor; SMA, smooth muscle actin.
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of estrogen therapy, which indicates an underlying asso-
ciation between estrogen and MESTK. However, there
are some rare male [5,7-9] or pediatric [7,10,11] cases.
In our series, most of the female patients were middle-
aged peri-menopausal to older women. This implies that
a disturbed hormonal environment contributes to the
pathogenesis of MESTK; however, we did not observe
any correlation between estrogen therapy and MESTK,
as all the patients denied histories of hormonal therapy.
Thus, whether estrogen therapy is indeed associated
with MESTK warrants further study.
The most common clinical presentations of MESTK
include palpable abdominal mass, flank pain, and
hematuria. However, in our series, almost all the cases
were asymptomatic, and wee detected only incidentally
during regular investigation. Radiologically, MESTK ap-
pears as well-circumscribed multi-septate cystic mass with
solid components and thick or thin septa on both CT and
magnetic resonance imaging scans, and thus can mimicFigure 1 Representative radiological findings of mixed epithelial and
tomography scan showed a left renal tumor with cystic and solid compon
showed a giant, well-circumscribed, multi-cystic tumor that had originatedcomplex renal cyst or cystic nephroma [12-14]. Lack of any
typical radiological features makes it difficult to establish a
precise diagnosis of MESTK preoperatively [3], thus, most
cases are confirmed postoperatively, as in our series.
Histologically, MESTK is a dimorphic tumor composed
of cysts and tubules embedded in the spindle cell stroma.
The histogenesis of MESTK is unknown, and it has been
proposed that both components of the tumor, stromal and
epithelial, are neoplastic [15] and probably arise from a
common cell of origin [16]. Miscroscopically, the stroma
may resemble ovarian stroma, both morphologically and
immunohistochemically (Figure 2B,C), and is composed of
clusters of tubules or cystically dilated glands with variable
lining [17]. Immunohistochemically, the epithelial compo-
nents are usually positive for epithelial membrane antigen
and cytokeratin. Spindle cells usually show diffusely and
strongly positive immunostaining with desmin (Figure 2D),
smooth muscle actin, and vimentin (Figure 2E). In addition,
there is a high frequency of estrogen and progesterone re-
ceptor present in the nuclei of the spindle cells (Figure 2F).stromal tumor of the kidney. (A) Patient 3. Abdominal computed
ents. (B) Patient 7. T2-weighted coronal magnetic resonance imaging
from the right kidney.
Figure 2 Representative pathological findings of mixed epithelial and stromal tumor of the kidney. (A) MESTK showed characteristic
biphasic components, including tubules embedded in the spindle cell stroma. (B) The mesenchymal component resembled that of densely
cellular ovarian stroma. (C) The ovarian-like stroma underwent myxoid change. (D) Smooth muscle marker such as desmin was strongly positive
in the stroma of MESTK. (E) The stroma showed a positive reaction against vimentin. (F) Progesterone receptors were seen in the nuclei of the
stromal cells of MESTK.
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support the hypothesis that hormonal hyperstimulation
contributes to tumorigenesis of MESTK.
MESTK used to be categorized as a benign renal tumor
without recurrence or metastasis. However, malignant
transformation of MESTK has been recently recognized,
and a small number of aggressive cases with varied trans-
formation have been described in the literature [8,9,18-21].
All of these malignant cases were female patients with the
exception of one male patient reported by Suzuki et al.
[8,22]. The prognosis for malignant MESTK varies from
cases to cases, with half of the reported cases considered to
have a dismal prognosis. There is no established predictor
for prognosis, thus the histogenesis and clinical behavior of
MESTK warrants further study.
Conclusions
MESTK is a rare clinical entity. It is generally considered
to be a benign tumor with good prognosis, but there is
malignant potential. MESTK should be considered as a
possible diagnosis in cases of cystic renal mass, especially
in peri-menopausal women or those who have received
hormonal therapy.
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